Search Within

Gregory J Riely

  1. "Robert Heelan"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Thoracic Oncology (9)
  4. Department of Pathology and Laboratory Medicine (5)
  5. GSK Faculty (4)
  6. Human Oncology and Pathogenesis Program (4)

More Groups

People
  1. Mark Kris (9)
  2. Robert Heelan (9)
  3. Vincent Miller (9)
  4. William Pao (6)
  5. Christopher Azzoli (4)
  6. Marc Ladanyi (4)

More People

Years
  1. 2011 (1)
  2. 2010 (1)
  3. 2008 (2)
  4. 2007 (1)
  5. 2006 (1)
  6. 2005 (3)
Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer (1)
  3. Cancer Chemotherapy and Pharmacology (1)
  4. Journal of Thoracic Oncology (1)
  5. PLos Medicine (1)
Publishers
  1. American Society of Clinical Oncology (5)
  2. Elsevier Inc. (1)
  3. Public Library of Science (1)
  4. Springer (1)
  5. Wiley Blackwell (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of weekly albumin-bound paclitaxel (Abraxane ®) given as a two-hour infusion
    Journal Article

    Paik, P. K.; James, L. P.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Sima, C. S.; Heelan, R. T.; Kris, M. G.; Moore, E.; more...
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save
  • Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer
    Journal Article

    Price, K. A.; Azzoli, C. G.; Krug, L. M.; Pietanza, M. C.; Rizvi, N. A.; Pao, W.; Kris, M. G.; Riely, G. J.; Heelan, R. T.; Arcila, M. E.; more...
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save
  • Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer
    Journal Article

    Rizvi, N. A.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Fiore, J.; Chia, G.; Brower, M.; Heelan, R.; Hawkins, M. J.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib
    Journal Article

    Miller, V. A.; Riely, G. J.; Zakowski, M. F.; Li, A. R.; Patel, J. D.; Heelan, R. T.; Kris, M. G.; Sandler, A. B.; Carbone, D. P.; Tsao, A.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer
    Journal Article

    Milton, D. T.; Riely, G. J.; Azzoli, C. G.; Gomez, J. E.; Heelan, R. T.; Kris, M. G.; Krug, L. M.; Pao, W.; Pizzo, B.; Rizvi, N. A.; more...
    Cancer (2007)

    Fulltext@MSK | Save
  • Molecular on/off switch
    Journal Article

    Milton, D. T.; Riely, G. J.; Pao, W.; Miller, V. A.; Kris, M. G.; Heelan, R. T.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib
    Meeting Abstract

    Riely, G. J.; Miller, V. A.; Pao, W.; Zakowski, M.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • EGFR mutation, immumohistochemistry (IHC) and chromogenic in situ hybridization (CISH) as predictors of sensitivity to erlotinib and gefitinib in patients (pts) with NSCLC
    Meeting Abstract

    Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Hussain, S.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    Journal Article

    Pao, W.; Wang, T. Y.; Riely, G. J.; Miller, V. A.; Pan, Q.; Ladanyi, M.; Zakowski, M. F.; Heelan, R. T.; Kris, M. G.; Varmus, H. E.
    PLos Medicine (2005)

    Fulltext@MSK | Save